Content |
Main article: Viruses
Chronicle
2025: Global Epidemiological Surveillance Solutions Market Size for the Year Reached $940 Million
In 2025, costs in the global market for solutions for epidemiological surveillance of infections amounted to $939.6 million. More than 40% of this amount fell on the North American region. Such data are provided in a Fortune Business Insights study, the results of which were published on January 13, 2026.
Solutions for epidemiological surveillance are a set of measures, technologies and tools for the systematic collection and analysis of data on diseases and risk factors, the identification of patterns of the spread of infection, the assessment of the situation and the development of effective preventive (anti-epidemic) measures. Such means help to determine the scale, trends and factors affecting the spread of infection - for example, in hospitals, among certain groups of the population, etc. Specialized tools provide an opportunity to predict risks, make informed decisions, and develop long-term and short-term strategies aimed at protecting public health and preventing disease outbreaks.
One of the drivers of the analytics market is called the integration of artificial intelligence. Neural networks are able to quickly analyze huge arrays of heterogeneous information from various sources to identify cases of nosocomial infections and identify patients at risk in the early stages. AI algorithms allow you to automate resource-intensive tasks and minimize the number of errors caused by the human factor. Special predictive models based on AI are being introduced.
An increasing prevalence of nosocomial infections is having a stimulating effect on the industry. According to the World Health Organization (WHO), released in 2022, during hospitalization, seven patients out of 100 in high-income countries and 15 patients out of 100 in low- and middle-income countries contract at least one healthcare-related infection. On average, in one in ten of these patients, nosocomial infection is fatal. The high-risk group includes patients in intensive care units and newborns. Against this background, the demand for solutions for epidemiological surveillance of infections in medical institutions is growing.
At the same time, a number of restraining factors stand out. These include limited IT resources and high implementation costs associated with significant initial investments in software, hardware, interoperability with existing systems, etc. In addition, there may be difficulties in integrating with electronic medical records.
The market is segmented into software and services: in 2025, the lion's share of revenue - more than 60% - was provided by software. The deployment model is dominated by cloud platforms due to their flexibility, cost-effectiveness, and scalability. From a geographical point of view, North America leads with 44.8%, or $421.2 million (against $405.4 million in 2024). Major industry players on a global scale are:
- BD;
- Premier;
- Wolters Kluwer;
- Clinisys;
- Oracle;
- Gojo Industries;
- Baxter;
- RLDatix;
- Epic Systems.
In 2026, the market for solutions for epidemiological surveillance of infections is expected to reach $1.04 billion. Fortune Business Insights analysts forecast a compound percentage CAGR of 10.91% going forward. Thus, by 2034, costs may increase to $2.38 billion.[1]
